1 (Image 1)
Metoprolol Succinate Tablet, Film Coated, Extended Release
Product Images NDC 45963-709
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 45963-709). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
1 (Image 10)
1 (Image 11)
Metoprolol Succinate is a medicine that is available in the form of extended-release tablets. The tablets come in a pack of 100 and contain 25 mg of metoprololsuccinate, which is equivalent to 25 mg of metoprolol arirte. Each tablet is film-coated and should be dispensed in a tight, light-resistant container as defined in the USP. The usual dosage should be determined by consulting the accompanying literature for full prescribing information. The medication should be stored at 25° (77°F) with excursions permitted 015 10 30°C (59° 10 86°F) [see USP Controlled Room Temperature]. This medication should be kept out of the reach of children. Unfortunately, there is no information available in the text that can identify the medical purpose of this medication.*
1 (Image 12)
NDC 45963-676-11 is a medication called Metoprolol Succinate that comes in the form of Extended-Release Tablets, USP with a strength of 50 mg. This particular package contains 100 tablets manufactured by TEVA. Each tablet contains 47.5 mg of metoprolol succinate, USP equivalent to 50 mg of metoprolol tartrate, USP. The medication should be kept in a tight, light-resistant container as defined by the USP and should be stored at room temperature between 59°F and 86°F. The usual dosage and prescribing information is available in the accompanying literature. This medication should be kept out of reach of children. LOTIEXP can be found below.*
1 (Image 13)
Metoprolol Succinate Extended-Release Tablets, USP are a prescription medication that contains 95 mg of metoprolol succinate, USP which is equivalent to 100mg of metoprolol tartrate, USP. The medication is used to treat hypertension (high blood pressure) and angina pectoris (chest pain). The usual dosage should be determined by accompanying literature or a healthcare professional. The tablets are film-coated and are available as 100 tablets in each bottle. Store at controlled room temperature.*
1 (Image 14)
Metoprolol Succinate is a medication available in the form of extended-release tablets, with a strength of 200 mg. The tablets contain 190 mg of Metoprolol Succinate, equivalent to 200 mg of metoprolol tartrate. The drug should be stored in a tightly closed, light-resistant container at 25°C. The usual dosage should be determined using the accompanying literature. This medication is manufactured by Teva Pharmaceuticals USA, Inc. and should be kept out of the reach of children. The given text seems to be a label or description of the drug.*
1 (Image 2)
1 (Image 3)
1 (Image 4)
2 (Image 5)
1 (Image 6)
Results for Subgroups in MERIT-HF are not clearly available.*
1 (Image 7)
1 (Image 8)
1 (Image 9)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
